<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>200125</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11145724</PubmedId>
            <Abstract>The sequence of the hepatitis B virus (HBV) major envelope (Env) protein (ayw subtype) was scanned for the presence of H-2(d,b) motifs. Following binding and immunogenicity testing, two new H-2(d)-restricted epitopes (Env.362 and Env.364) were identified. These epitopes induced CTLs capable of recognizing naturally processed HBV-Env, but were apparently generated with lower efficiency than the previously defined dominant Env.28 epitope. Next, HBV-transgenic mice that express all of the HBV proteins and produce fully infectious particles were immunized with a mixture of lipopeptides encompassing the Env.28, Env.362, and Env.364 epitopes. Significant CTL responses were obtained, but they had no effect on viral replication in the liver, nor did they induce an inflammatory liver disease. However, in adoptive transfer experiments, CTL lines generated from the HBV-transgenic mice following immunization were able to inhibit viral replication in vivo without causing hepatitis. This is in contrast to CTL lines derived from nontransgenic mice that displayed both antiviral and cytopathic effects, presumably because they displayed higher avidity for the viral epitopes than the transgenic CTLs. These results suggest that T cell tolerance to HBV can be broken with appropriate immunization but the magnitude and characteristics of the resultant T cell response are significantly different from the response in HBV-naive individuals since their antiviral potential is stronger than their cytotoxic potential. This has obvious implications for immunotherapy of chronic HBV infection.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>1389-97</ArticlePages>
            <ArticleTitle>Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Sette</LastName>
                    <ForeName>A D</ForeName>
                </Author>
                <Author>
                    <LastName>Oseroff</LastName>
                    <ForeName>C</ForeName>
                </Author>
                <Author>
                    <LastName>Sidney</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Alexander</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Chesnut</LastName>
                    <ForeName>R W</ForeName>
                </Author>
                <Author>
                    <LastName>Kakimi</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Guidotti</LastName>
                    <ForeName>L G</ForeName>
                </Author>
                <Author>
                    <LastName>Chisari</LastName>
                    <ForeName>F V</ForeName>
                </Author>
            </Authors>
            <Affiliations>Epimmune, Inc., San Diego, CA 92121. Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92121, USA. asette@epimmune.com.</Affiliations>
            <ArticleChemicalList>Epitopes, T-Lymphocyte;Hepatitis B Surface Antigens;Immunodominant Epitopes;Peptide Fragments;Viral Envelope Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adoptive Transfer; Animals; Antigen Presentation(genetics); Cytotoxicity, Immunologic(genetics); Dose-Response Relationship, Immunologic; Down-Regulation(genetics; immunology); Epitopes, T-Lymphocyte(immunology; metabolism); Hepatitis B(genetics; immunology; pathology); Hepatitis B Surface Antigens(biosynthesis; immunology; metabolism); Hepatitis B virus(genetics; immunology); Immune Tolerance(genetics); Immunodominant Epitopes(immunology; metabolism); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments(immunology; metabolism); T-Lymphocytes, Cytotoxic(immunology; metabolism; transplantation; virology); Tumor Cells, Cultured; Viral Envelope Proteins(genetics; immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>166</Volume>
                <Issue>2</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ASARFSWL</LinearSequence>
                        <StartingPosition>329</StartingPosition>
                        <EndingPosition>336</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>4327</EpitopeId>
                <ReferenceStartingPosition>328</ReferenceStartingPosition>
                <ReferenceEndingPosition>335</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206481</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>300.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CLIFLLVL</LinearSequence>
                        <StartingPosition>253</StartingPosition>
                        <EndingPosition>260</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>6584</EpitopeId>
                <ReferenceStartingPosition>252</ReferenceStartingPosition>
                <ReferenceEndingPosition>259</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206482</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>6000.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DPALNMENI</LinearSequence>
                        <StartingPosition>159</StartingPosition>
                        <EndingPosition>167</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>9596</EpitopeId>
                <ReferenceStartingPosition>158</ReferenceStartingPosition>
                <ReferenceEndingPosition>166</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206483</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ENITSGFL</LinearSequence>
                        <StartingPosition>165</StartingPosition>
                        <EndingPosition>172</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>13494</EpitopeId>
                <ReferenceStartingPosition>164</ReferenceStartingPosition>
                <ReferenceEndingPosition>171</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206484</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FIIFLFIL</LinearSequence>
                        <StartingPosition>243</StartingPosition>
                        <EndingPosition>250</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>16213</EpitopeId>
                <ReferenceStartingPosition>242</ReferenceStartingPosition>
                <ReferenceEndingPosition>249</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206485</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>5000.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FVQWFVGL</LinearSequence>
                        <StartingPosition>342</StartingPosition>
                        <EndingPosition>349</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>18270</EpitopeId>
                <ReferenceStartingPosition>341</ReferenceStartingPosition>
                <ReferenceEndingPosition>348</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206486</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>150.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPSLYSIL</LinearSequence>
                        <StartingPosition>365</StartingPosition>
                        <EndingPosition>372</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>21786</EpitopeId>
                <ReferenceStartingPosition>364</ReferenceStartingPosition>
                <ReferenceEndingPosition>371</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206487</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IIFLFILL</LinearSequence>
                        <StartingPosition>244</StartingPosition>
                        <EndingPosition>251</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>26483</EpitopeId>
                <ReferenceStartingPosition>243</ReferenceStartingPosition>
                <ReferenceEndingPosition>250</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206488</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>7500.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ILSPFLPL</LinearSequence>
                        <StartingPosition>371</StartingPosition>
                        <EndingPosition>378</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>27344</EpitopeId>
                <ReferenceStartingPosition>370</ReferenceStartingPosition>
                <ReferenceEndingPosition>377</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206489</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>469.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                        <StartingPosition>191</StartingPosition>
                        <EndingPosition>202</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>28023</EpitopeId>
                <ReferenceStartingPosition>190</ReferenceStartingPosition>
                <ReferenceEndingPosition>201</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 4 and 5, Figure 4</LocationOfData>
                        <TCellId>1356257</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 28</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>126</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>P815 cells expressing the surface antigen were not significantly recognized by CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence. Since the epitope is accesible to non-trangenic CTLs, the lack of recognition is suggestive of T cell tolerance. Nevertheless, some IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 2 and 3, Figures 1 and 4.</LocationOfData>
                        <TCellId>1356182</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 28</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope or with a pool of peptides including this one, in a lipopeptide construct (with 2 Palmitic acid moieties and the PADRE T helper epitope).  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6-10 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>126</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 28</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                        <StartingPosition>191</StartingPosition>
                                        <EndingPosition>202</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>18</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>17</NumberOfSubjectsResponded>
                            <ResponseFrequency>94.4</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised by in vivo and in vitro induction with the peptide. Also IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1356393</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 28</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days twice to generate  short-term CTL lines.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>126</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IFN-gamma production from CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence, is obtained when confronted with target cells expressing the surface antigen. Citotoxicity could not be detected, but cytokine production seems to have overcome the tolerance in this system. This correlates with the HBV replication control after adoptive transfer of these cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 4, Table 4</LocationOfData>
                        <TCellId>1356256</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 28</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope, or with a  pool of peptides including this one, in a lipopeptide construct (with 2 Palmitic acid moieties and the PADRE T helper epitope).  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6-10 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>126</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P815 cells expressing the surface antigen were recognized by CTL raised by in vivo and in vitro induction with the peptide. Also IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 3 and 4, Figures 3 and 4</LocationOfData>
                        <TCellId>1356392</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 28</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                            <StartingPosition>191</StartingPosition>
                                            <EndingPosition>202</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>126</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 28</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPQSLDSWWTSL</LinearSequence>
                                        <StartingPosition>191</StartingPosition>
                                        <EndingPosition>202</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence, suggesting the formulation used allowed to overcome T cell tolerance.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206490</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.4</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>126</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LCLIFLLV</LinearSequence>
                        <StartingPosition>252</StartingPosition>
                        <EndingPosition>259</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>35075</EpitopeId>
                <ReferenceStartingPosition>251</ReferenceStartingPosition>
                <ReferenceEndingPosition>258</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206491</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LFILLLCL</LinearSequence>
                        <StartingPosition>247</StartingPosition>
                        <EndingPosition>254</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>35856</EpitopeId>
                <ReferenceStartingPosition>246</ReferenceStartingPosition>
                <ReferenceEndingPosition>253</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206492</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LLPIFFCL</LinearSequence>
                        <StartingPosition>378</StartingPosition>
                        <EndingPosition>385</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>37663</EpitopeId>
                <ReferenceStartingPosition>377</ReferenceStartingPosition>
                <ReferenceEndingPosition>384</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206493</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LQAGFFLL</LinearSequence>
                        <StartingPosition>178</StartingPosition>
                        <EndingPosition>185</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>38803</EpitopeId>
                <ReferenceStartingPosition>177</ReferenceStartingPosition>
                <ReferenceEndingPosition>184</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206494</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LSSIFSRI</LinearSequence>
                        <StartingPosition>150</StartingPosition>
                        <EndingPosition>157</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>39658</EpitopeId>
                <ReferenceStartingPosition>149</ReferenceStartingPosition>
                <ReferenceEndingPosition>156</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206495</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>3333.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LYSILSPFL</LinearSequence>
                        <StartingPosition>368</StartingPosition>
                        <EndingPosition>376</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>40954</EpitopeId>
                <ReferenceStartingPosition>367</ReferenceStartingPosition>
                <ReferenceEndingPosition>375</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206496</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>2500.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>124</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MWYWGPSL</LinearSequence>
                        <StartingPosition>361</StartingPosition>
                        <EndingPosition>368</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>43030</EpitopeId>
                <ReferenceStartingPosition>360</ReferenceStartingPosition>
                <ReferenceEndingPosition>367</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206497</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>7500.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PGYRWMCL</LinearSequence>
                        <StartingPosition>233</StartingPosition>
                        <EndingPosition>240</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>47795</EpitopeId>
                <ReferenceStartingPosition>232</ReferenceStartingPosition>
                <ReferenceEndingPosition>239</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206498</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PSDGNCTCI</LinearSequence>
                        <StartingPosition>305</StartingPosition>
                        <EndingPosition>313</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>49312</EpitopeId>
                <ReferenceStartingPosition>304</ReferenceStartingPosition>
                <ReferenceEndingPosition>312</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206499</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>172</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RFIIFLFI</LinearSequence>
                        <StartingPosition>242</StartingPosition>
                        <EndingPosition>249</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>53721</EpitopeId>
                <ReferenceStartingPosition>241</ReferenceStartingPosition>
                <ReferenceEndingPosition>248</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206500</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SRIGDPAL</LinearSequence>
                        <StartingPosition>155</StartingPosition>
                        <EndingPosition>162</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>60697</EpitopeId>
                <ReferenceStartingPosition>154</ReferenceStartingPosition>
                <ReferenceEndingPosition>161</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206501</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TCPGYRWM</LinearSequence>
                        <StartingPosition>231</StartingPosition>
                        <EndingPosition>238</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>63093</EpitopeId>
                <ReferenceStartingPosition>230</ReferenceStartingPosition>
                <ReferenceEndingPosition>237</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206502</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>417</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <QuantitativeMeasurement>10000.0</QuantitativeMeasurement>
                            <MeasurementInequality>&gt;</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGPCRTCMT</LinearSequence>
                        <StartingPosition>281</StartingPosition>
                        <EndingPosition>289</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>63919</EpitopeId>
                <ReferenceStartingPosition>280</ReferenceStartingPosition>
                <ReferenceEndingPosition>288</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <TCellId>1356625</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000108</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TGPCRTCMT</LinearSequence>
                                            <StartingPosition>281</StartingPosition>
                                            <EndingPosition>289</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 281</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>TGPCRTCMT</LinearSequence>
                                            <StartingPosition>281</StartingPosition>
                                            <EndingPosition>289</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6 days.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>173</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 281</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>TGPCRTCMT</LinearSequence>
                                        <StartingPosition>281</StartingPosition>
                                        <EndingPosition>289</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>10</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>20</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised by in vivo and in vitro induction with the peptide.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206503</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Intermediate</QualitativeMeasurement>
                            <QuantitativeMeasurement>115.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>173</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TGPCRTCMTT</LinearSequence>
                        <StartingPosition>281</StartingPosition>
                        <EndingPosition>290</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>63920</EpitopeId>
                <ReferenceStartingPosition>280</ReferenceStartingPosition>
                <ReferenceEndingPosition>289</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206504</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>4286.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>173</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VLLDYQGM</LinearSequence>
                        <StartingPosition>259</StartingPosition>
                        <EndingPosition>266</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>69580</EpitopeId>
                <ReferenceStartingPosition>258</ReferenceStartingPosition>
                <ReferenceEndingPosition>265</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206505</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>3333.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>WGPSLYSIL</LinearSequence>
                        <StartingPosition>364</StartingPosition>
                        <EndingPosition>372</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>72500</EpitopeId>
                <ReferenceStartingPosition>363</ReferenceStartingPosition>
                <ReferenceEndingPosition>371</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 2 and 3, Figures 1 and 4.</LocationOfData>
                        <TCellId>1356626</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 364</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope or with a pool of peptides including this one, in a lipopeptide construct (with 2 Palmitic acid moieties and the PADRE T helper epitope).  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6-10 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>173</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 364</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WGPSLYSIL</LinearSequence>
                                        <StartingPosition>364</StartingPosition>
                                        <EndingPosition>372</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>14</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>12</NumberOfSubjectsResponded>
                            <ResponseFrequency>85.7</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised by in vivo and in vitro induction with the peptide. Also IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 4 and 5, Figure 4</LocationOfData>
                        <TCellId>1356629</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 364</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>173</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>P815 cells expressing the surface antigen were not significantly recognized by CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence. Since the epitope is accesible to non-trangenic CTLs, the lack of recognition is suggestive of T cell tolerance. Nevertheless, some IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 4, Table 4</LocationOfData>
                        <TCellId>1356260</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 364</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope, or with a  pool of peptides including this one, in a lipopeptide construct (with 2 Palmitic acid moieties and the PADRE T helper epitope).  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6-10 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>173</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P815 cells expressing the surface antigen were recognized by CTL raised by in vivo and in vitro induction with the peptide. Also IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 3 and 4, Figures 3 and 4</LocationOfData>
                        <TCellId>1356630</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 364</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>173</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 364</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WGPSLYSIL</LinearSequence>
                                        <StartingPosition>364</StartingPosition>
                                        <EndingPosition>372</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence, suggesting the formulation used allowed to overcome T cell tolerance.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1356631</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 364</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WGPSLYSIL</LinearSequence>
                                            <StartingPosition>364</StartingPosition>
                                            <EndingPosition>372</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days twice to generate  short-term CTL lines.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>173</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IFN-gamma production from CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence, is obtained when confronted with target cells expressing the surface antigen. Citotoxicity could not be detected, but cytokine production seems to have overcome the tolerance in this system. This correlates with the HBV replication control after adoptive transfer of these cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206506</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>5.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>173</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>WYWGPSLYSI</LinearSequence>
                        <StartingPosition>362</StartingPosition>
                        <EndingPosition>371</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>73301</EpitopeId>
                <ReferenceStartingPosition>361</ReferenceStartingPosition>
                <ReferenceEndingPosition>370</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 4 and 5, Figure 4</LocationOfData>
                        <TCellId>1356632</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 362</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>P815 cells expressing the surface antigen were not significantly recognized by CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence. Since the epitope is accesible to non-trangenic CTLs, the lack of recognition is suggestive of T cell tolerance. Nevertheless, some IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>1356634</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 362</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days twice to generate  short-term CTL lines.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>IFN-gamma production from CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence, is obtained when confronted with target cells expressing the surface antigen. Citotoxicity could not be detected, but cytokine production seems to have overcome the tolerance in this system. This correlates with the HBV replication control after adoptive transfer of these cells.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 1 and 4, Table 4</LocationOfData>
                        <TCellId>1356261</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 362</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope, or with a  pool of peptides including this one, in a lipopeptide construct (with 2 Palmitic acid moieties and the PADRE T helper epitope).  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6-10 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Major surface antigen precursor</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>P815 cells expressing the surface antigen were recognized by CTL raised by in vivo and in vitro induction with the peptide. Also IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 3 and 4, Figures 3 and 4</LocationOfData>
                        <TCellId>1356633</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000245</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 362</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Peptide conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 10 μg lipopeptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>The hepatocytes from these animals express all of the HBV gene products and replicate HBV at high levels in the liver without any evidence of cytopathology. Lineage 1.3.32 mice C57BL/6 (H-2b) were backcrossed one generation against BALB/c (H-2d) mice to produce H-2bxd F1 (CB6F1) hybrids for this study. Mice were immunized in the base of the tail with a pool of lipopeptide constructs, including the one made with this peptide. Each peptide is linked to 2 Palmitic acid moieties and the PADRE T helper epitope.  Splenocytes obtained 11-14 days after immunization were incubated with free peptide and irradiated APCs for 6 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.The carrier consisted of the PADRE peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 362</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WYWGPSLYSI</LinearSequence>
                                        <StartingPosition>362</StartingPosition>
                                        <EndingPosition>371</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised in transgenic mice expressing the complete HBV genome in the  hepatocytes, by in vivo induction with a lipopeptide configuration of this sequence, suggesting the formulation used allowed to overcome T cell tolerance.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Tables 2 and 3, Figures 1 and 4.</LocationOfData>
                        <TCellId>1356627</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Env. 362</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>1 dose of 50 μg peptide</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>Splenocyte</ResponderCellType>
                                <StimulatorCellType>B cell</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>WYWGPSLYSI</LinearSequence>
                                            <StartingPosition>362</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P03138.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10418</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were immunized in the base of the tail with the peptide in IFA along with an excess (140μg) of OVA.323 helper epitope or with a pool of peptides including this one, in a lipopeptide construct (with 2 Palmitic acid moieties and the PADRE T helper epitope).  Splenocytes obtained 11-14 days after immunization were incubated with peptide and irradiated APCs for 6-10 days. In some experiments, short-term CTL lines were used, generated with a second round of restimulation.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Env. 362</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>WYWGPSLYSI</LinearSequence>
                                        <StartingPosition>362</StartingPosition>
                                        <EndingPosition>371</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03138.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10418</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>12</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>7</NumberOfSubjectsResponded>
                            <ResponseFrequency>58.3</ResponseFrequency>
                            <AssayComments>Peptide loaded target cells were recognized by CTL raised by in vivo and in vitro induction with the peptide. Also IFN-gamma production could be detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206507</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-High</QualitativeMeasurement>
                            <QuantitativeMeasurement>16.0</QuantitativeMeasurement>
                        </AssayInformation>
                        <MhcAlleleId>124</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YSILSPFL</LinearSequence>
                        <StartingPosition>369</StartingPosition>
                        <EndingPosition>376</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03138.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10418</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>75765</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>375</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Imported from the TopBank database.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 1</LocationOfData>
                        <MhcBindingId>206508</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>1</AssayTypeId>
                            <QualitativeMeasurement>Positive-Low</QualitativeMeasurement>
                            <QuantitativeMeasurement>1111.0</QuantitativeMeasurement>
                            <AssayComments>The MHC binding activity of this peptide is considered poor since its IC50 is &gt;500nM.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>122</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

